Stevanto Group tackling flexible drug containment packages and filling solutions
Outsourcing Pharma
JANUARY 30, 2024
Two new offerings have been unveiled by drug delivery and solutions provider, Stevanto Group S.p.A.
This site uses cookies to improve your experience. By viewing our content, you are accepting the use of cookies. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country we will assume you are from the United States. View our privacy policy and terms of use.
Outsourcing Pharma
JANUARY 30, 2024
Two new offerings have been unveiled by drug delivery and solutions provider, Stevanto Group S.p.A.
Drug Discovery World
OCTOBER 19, 2022
Ashley Rein , Global Market Manager for Topical Drug Delivery at Lubrizol Life Science Health (LLS Health), explains how by using mucoadhesive drug delivery, developers can bring novel drugs to market and maximise the efficacy of pre-existing APIs. . Consider drug delivery systems early on .
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Outsourcing Pharma
JANUARY 30, 2024
Two new offerings have been unveiled by drug delivery and solutions provider, Stevanto Group S.p.A.
Drug Discovery World
AUGUST 4, 2022
It may seem counterintuitive to spend time and money on planning for containment and delivery systems for a drug in the earliest stages of discovery when the chances of that molecule making it to market are still quite low. Food and Drug Administration (FDA) for approval of drug-device combinations.
Scienmag
JANUARY 8, 2021
Dill/NIST In a technique known as DNA origami, researchers fold long strands of DNA over and over again to construct a variety of tiny 3D structures, including miniature biosensors and drug-delivery containers.
Pharmaceutical Technology
FEBRUARY 27, 2023
Antares Pharma’s injectables are available in disposable multi-dose pen injectors and unit dose containers. The company employs drug delivery systems to advance drug compounds and drug delivery methods. It caters its subcutaneous injection technology platforms to both generic and branded injectables.
Pharmaceutical Technology
SEPTEMBER 20, 2022
The information contained within the download document is intended for pharmaceutical manufacturers, wholesalers, retailers and distributors, pharmaceutical executives, medical representatives, business development managers, retail salesmen, sales managers, pharmacy executives, and any other individual involved in pharmaceutical marketing.
Pharmaceutical Technology
SEPTEMBER 8, 2022
Pharmaceutical solid dosage forms are the most popular in the pharmaceutical industry and are one of the most used drug delivery methods across patient groups. The download contains detailed information on the providers and their services and solutions, alongside contact details to aid your purchasing or hiring decision.
BioTech 365
AUGUST 17, 2021
the “Company”), a leading global provider of drug containment, drug delivery and diagnostic solutions to the … Continue reading →
BioTech 365
JULY 7, 2021
the “Company”), a leading global provider of drug containment, drug delivery and diagnostic solutions to the … Continue reading →
XTalks
JUNE 14, 2023
XTALKS WEBINAR: Drug Delivery — Evaluating Off-The-Shelf and Novel Drug Delivery Solutions Live and On-Demand: Tuesday, July 11, 2023, at 1pm EDT (10am PDT) Register for this free webinar to learn about important tradeoffs when considering an off-the-shelf (OTS) drug delivery platform vs. novel development.
Drug Discovery World
JULY 31, 2023
Darren Mercer, Chief Executive of CSP, said: “We are thrilled to acquire AxeroVision, and in particular the pipeline product AXR-270 which contains a novel selective glucocorticoid receptor agonist formulated in a cutting-edge drug delivery system that overcomes the issues of poor compliance and inefficient delivery of conventional eye drops. “On
Roots Analysis
AUGUST 8, 2023
The hydrophobic portion contains two fatty acid chains with 10-24 carbon atoms, while the hydrophilic part primarily consists of phosphoric acid linked to a water-soluble molecule. Therapeutic Applications of Liposomes in Drug Delivery In comparison to existing formulations, liposomes offer greater therapeutic efficacy and safety.
pharmaphorum
NOVEMBER 17, 2021
The Future of Drug Delivery and Combination Product Device Design. The pre-filled syringes industry is growing at an exponential rate with innovations in parenteral delivery device development to aid self-administration and deliver biologics, high concentration, and large-volume drug products.
Roots Analysis
MARCH 8, 2023
Over time, various research studies have demonstrated the potential of exosomes ( membrane bound extracellular vesicles) in disease diagnosis, drug delivery and therapeutic applications. Targeted Drug Delivery: Ability to cross blood brain barrier cause lesser systemic effects and low toxicity.
Drug Discovery World
AUGUST 9, 2023
Darren Mercer, Chief Executive of CSP, said: “We are thrilled to acquire AxeroVision, and in particular the pipeline product AXR-270 which contains a novel selective glucocorticoid receptor agonist formulated in a cutting-edge drug delivery system that overcomes the issues of poor compliance and inefficient delivery of conventional eye drops.”
The Pharma Data
DECEMBER 20, 2020
With this acquisition we are expanding our product pipeline to include psychedelic therapeutics, incorporating elements of our IP around drug delivery technology in which we already have prototypes developed, which we believe will propel us towards clinical studies relatively quickly. Ahmad Doroudian, CEO of BetterLife.
XTalks
JANUARY 17, 2023
The US Food and Drug Administration (FDA) granted approval to AstraZeneca’s Airsupra (albuterol/budesonide), formerly known as PT027, for the as-needed treatment or prevention of bronchoconstriction and to reduce the risk of asthma attacks in individuals aged 18 years and older who have asthma.
Pharmaceutical Technology
OCTOBER 26, 2022
It indicates that nanomedicine also has the potential to combat the threat of antibiotic resistance via the use of nanomaterials with intrinsic antibacterial properties, as well as using nanoparticles as effective drug delivery systems for antibacterial agents. No mock-up is necessary, saving weeks of time and considerable costs.
The Pharma Data
OCTOBER 27, 2020
On April 20, 2020, XPhyto announced a definitive development, technology purchase and licence agreement with 3a-Diagnostics for the development and commercialization of real-time, low-cost and easy-to-use screening tests using 3a’s pathogen specific biosensors and XPhyto’s oral dissolvable drug delivery platform.
The Pharma Data
DECEMBER 28, 2020
is an emerging biotechnology company engaged in the development and commercialization of therapeutic pharmaceuticals as well as drug delivery platform technologies. Forward-looking statements contained in this news release are expressly qualified by this cautionary statement. About BetterLife Pharma Inc. BetterLife Pharma Inc.
The Pharma Data
NOVEMBER 2, 2020
. “Psychedelic agents are a promising new class of therapeutic drug. We see a natural opportunity to apply XPhyto’s drug formulation expertise and Vektor’s proven drug delivery platforms to these emerging APIs,” said Hugh Rogers, CEO and Director of XPhyto. About XPhyto Therapeutics Corp.
Roots Analysis
FEBRUARY 16, 2022
In earlier times, container closure integrity testing was not regarded as an essential step in the process of manufacturing. The company developing drug product through such an intense process, use to consider container closure system only for packaging of the product. [1] Container Closure Integrity Testing Services Market.
XTalks
JANUARY 18, 2023
Ayesha also talked about the FDA approval of AstraZeneca’s asthma inhaler Airsupra, the first-in-class drug that contains both a beta agonist and corticosteroid. Hear more about the new subvariant and why scientists are keeping a close eye on it.
Roots Analysis
FEBRUARY 18, 2022
Myeloid cells represent a group of cells containing granulocytes, monocytes, macrophages, mast cells and dendritic cells, which play a key role in innate immunity. These cells are found in abundance in the tumor microenvironment and inflamed areas. Our Social Media Platform. Web: [link]. LinkedIn: [link]. Twitter: [link]. Medium: [link].
The Pharma Data
OCTOBER 20, 2020
” Mr. Bliss joins TLC following interim roles in cellular therapy, drug delivery and combination therapy where he led efforts to confirm research outcomes and partner the various technologies. This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995.
The Pharma Data
JANUARY 18, 2021
Utilizing drug delivery platform technologies, BetterLife is refining and developing drug candidates from a broad set of complementary interferon-based technologies which have the potential to engage the immune system to fight virus infections, such as the coronavirus disease (COVID-19) and human papillomavirus (HPV).
The Pharma Data
JANUARY 3, 2021
Nanoform’s capabilities span the small to large molecule development space and the company focuses on solving key issues in drug solubility and bioavailability and on enabling novel drug delivery applications. Certified Adviser: Danske Bank A/S, Finland Branch, +358 40 562 1806. For more information please visit [link].
The Pharma Data
DECEMBER 14, 2020
is an emerging biotechnology company engaged in the development and commercialization of therapeutic pharmaceuticals as well as drug delivery platform technologies. Forward-looking statements contained in this news release are expressly qualified by this cautionary statement. About BetterLife Pharma Inc. BetterLife Pharma Inc.
The Pharma Data
JANUARY 3, 2021
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Except as required by law, TLC expressly disclaims any responsibility to update any forward-looking statement contained herein, whether as a result of new information, future events or otherwise.
FDA Law Blog
MARCH 12, 2024
It’s difficult to conclude from these statements, as FTC and Congress appear to have, that device patents categorically shouldn’t be listed in the Orange Book.
The Pharma Data
NOVEMBER 26, 2020
Nanoform’s capabilities span the small to large molecule development space and the company focuses on solving key issues in drug solubility and bioavailability and on enabling novel drug delivery applications. Certified Adviser: Danske Bank A/S, Finland Branch, +358 40 562 1806. For more information please visit [link].
Druggist
NOVEMBER 19, 2020
Formoterol, which belongs to a group of drugs called long-acting beta2-agonist ( LABA ). As we already learned from the above combination inhaler in asthma contains two ingredients, one of which is inhaled corticosteroid and the other LABA. A spacer may offer drug delivery benefits in a wider patient group. Able Spacer®.
Druggist
OCTOBER 21, 2020
Curanail Once Weekly 5% Fungal Nail Treatment Curanail Once Weekly Fungal Nail treatment contains 5% of amorolfine hydrochloride as an active ingredient. delivery Excilor – review of clinical effectiveness Sleven et al. Products which were found inactive in the experiment did not contain any organic acids.
The Pharma Data
JANUARY 31, 2021
Dr. Marco started working on drug delivery cardiovascular devices while in charge of Medical Affairs for Abbott Vascular where, following the Perclose Inc. CSI encourages you to consider all of these risks, uncertainties and other factors carefully in evaluating the forward-looking statements contained in this release.
The Pharma Data
NOVEMBER 9, 2020
is accelerating the next-generation drug delivery, diagnostic, and phytochemical investment opportunities: precision transdermal and oral dissolvable drug dosage forms; rapid, low-cost infectious disease and oral health screening tools; and validation of approved cannabinoid-based therapeutics focused on European markets.
The Pharma Data
NOVEMBER 4, 2020
is a bioscience accelerator focused on next-generation drug delivery, diagnostic, and phyto-therapeutic investment opportunities: precision transdermal and oral dissolvable drug dosage forms; rapid, low-cost infectious disease and oral health screening tools; and emerging plant-based therapeutics focused on European markets.
The Pharma Data
JANUARY 17, 2021
The Company is not making any express or implied claims that its product has the ability to eliminate, cure or contain the COVID-19 pandemic. This news release includes statements containing forward-looking information within the meaning of applicable Canadian securities law (“forward-looking statements”).
The Pharma Data
JUNE 26, 2021
About Port Delivery System with ranibizumab (PDS) PDS is a permanent refillable eye implant, approximately the size of a grain of rice, which is designed to continuously release a customised formulation of ranibizumab into the eye over time. 13 PDS contains a customised formulation of ranibizumab not approved by regulatory authorities.
The Pharma Data
DECEMBER 2, 2020
The company applies a multi-omics approach, combining genomics, epigenomics, proteomics, and metabolomics to its molecular testing products and to the development of a suite of investigational ingestible devices designed to provide precise diagnostic sampling and drug delivery solutions. Forward Looking Statements.
Drug Discovery World
AUGUST 3, 2022
These peptides typically contain up to 30 amino acids and can be cationic, amphipathic or both. Originally, GLP1R was viewed as unsuitable for selective drug delivery, due to its low abundance and restricted ability to internalise a large amount of drug conjugate. Here, Bachem explores the science behind this approach.
The Pharma Data
OCTOBER 27, 2020
The technology enhances the delivery of ingredients to and through the skin and is protected by patents in eleven countries. Information set forth in this news release contains forward-looking statements that are based on assumptions as of the date of this news release. Ovation trades on the CSE under the symbol OVAT.
The Pharma Data
NOVEMBER 4, 2020
The Company offers a portfolio of non-prescription skincare products and early to commercial stage prescription drug products and owns multiple proprietary drug delivery platforms that support the development of patented formulations that can facilitate the delivery of active ingredients into or through the skin.
The Pharma Data
DECEMBER 2, 2020
The company applies a multi-omics approach, combining genomics, epigenomics, proteomics, and metabolomics to its molecular testing products and to the development of a suite of investigational ingestible devices designed to provide precise diagnostic sampling and drug delivery solutions. Forward-Looking Statements.
Expert insights. Personalized for you.
We have resent the email to
Are you sure you want to cancel your subscriptions?
Let's personalize your content